Cargando…
A screen of FDA-approved drugs identifies inhibitors of protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3)
Protein tyrosine phosphatase 4A3 (PTP4A3 or PRL-3) is highly expressed in a variety of cancers, where it promotes tumor cell migration and metastasis leading to poor prognosis. Despite its clinical significance, small molecule inhibitors of PRL-3 are lacking. Here, we screened 1443 FDA-approved drug...
Autores principales: | Rivas, Dylan R., Dela Cerna, Mark Vincent C., Smith, Caroline N., Sampathi, Shilpa, Patty, Blaine G., Lee, Donghan, Blackburn, Jessica S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119466/ https://www.ncbi.nlm.nih.gov/pubmed/33986418 http://dx.doi.org/10.1038/s41598-021-89668-5 |
Ejemplares similares
-
Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) drives migration and progression of T-cell acute lymphoblastic leukemia in vitro and in vivo
por: Wei, M., et al.
Publicado: (2020) -
Targeted Deletion of the Metastasis-Associated Phosphatase Ptp4a3 (PRL-3) Suppresses Murine Colon Cancer
por: Zimmerman, Mark W., et al.
Publicado: (2013) -
Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) promotes the aggressiveness of human uveal melanoma through dephosphorylation of CRMP2
por: Duciel, Laura, et al.
Publicado: (2019) -
The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia
por: Zhou, Jianbiao, et al.
Publicado: (2012) -
Phosphatase and Pseudo-Phosphatase Functions of Phosphatase
of Regenerating Liver 3 (PRL-3) Are Insensitive to Divalent Metals
In Vitro
por: Jolly, Jeffery T., et al.
Publicado: (2023)